Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.

Author: , AliuErmal, Amlie-WolfLouise, AnanthAmitha L, AngioneKatie, AradhyaSwaroop, ArainAmir M, AssafMelissa J, BatleyKaitlin Y, BearJoshua J, Benítez AlonsoEdmar O, BergAnne T, BonkowskyJoshua L, BorlotFelippe, BoutlierSusan B, BoyarchukOksana, BristowSara L, BuppCaleb P, BurkeRebecca J, BurnsKaitlyn, CandeeMeghan S, CarsonRobert P, ChagnonSarah L, ChariGeetha, ChavdaDevraj, ChernuhaVeronika, Chirita-EmandiAdela, CostinCarrie E, DaoJasmin M, Dueñas-RoqueMilagros M, EschbachKrista, EspinozaA Chris, EsplinEdward D, FaheyMichael C, FalchekStephen, FelixTemis M, FillouxFrancis M, FreemanJeremy L, FultonStephen, Gonzalez-GiraldoErnesto, GuerraPatricio, GuzmánGuillermo G, HabelaChrista W, Haldeman-EnglertChad R, HammondKatherine C, HassanMuhammad Jawad, HatchellKathryn E, HumbersonJennifer B, HurstAnna C E, HwangSean T, JacobsonMona, JiangHuiyuan, KalikaPaige M, KammeyerRyan, KanhangadManoj, KarkareShefali, KelloggMarissa A, Kulasa-LukeDianne, KumarAshutosh, Lay-SonGuillermo, LevyRebecca J, LoraEvelyn G, LukeRebecca R, LupoPamela, MachieMichelle, MaletsMyroslava, MarshEric D, MassinghamLauren J, McKnightDianalee, MegarbaneAndre, MeibosBailey, MiroshnikovOleksandr, MohamedIsmail S, Monroy-SantoyoSusana, Montiel BlancoJohnny David, MoralesAna, MoretzChad, MuWeiyi, MullerEric, MurphyAndrea, NechaiAlla, NelsonGary R, NolanDanielle A, NolanMelinda, NussbaumRobert L, OstranderBetsy, PalmquistRachel, ParachuriVenu G, ParikhSumit, ParkKristen L, PavliukMariia, PedersenRobert C, PerryMichael Scott, PisaniLaura, PlazaLautaro, PressCraig A, Ramirez-GarciaMiguel Angel, RazaMuhammad, Reyes-SilvaCarlos Alberto, Rodriguez-VazquezNatalia, Rojas CarrionMiguel David, RyanMonique M, Ríos-PohlLoreto, SchatzKrista, SeinfeldSyndi, Shiloh-MalawskyYael, SilvaSebastian, SmithDouglas M, SogawaYoshimi, Soler-AlfonsoClaudia, StarksAngela, StetsenkoTetiana, SvystilnykVictoria, SweneyMatthew T, TrasmonteJoseph, TreatLauren, Van OrmanColin B, VenegasViviana, WeinstockArie, WhelessJames W, WilsonCarey A, WongKristen, ZarroliKatherine, ZiobroJulie, ZuccarelliBritton, de MontellanoDavid J Dávila-Ortiz

Paper Details 
Original Abstract of the Article :
IMPORTANCE: It is currently unknown how often and in which ways a genetic diagnosis given to a patient with epilepsy is associated with clinical management and outcomes. OBJECTIVE: To evaluate how genetic diagnoses in patients with epilepsy are associated with clinical management and outcomes. DES...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623482/

データ提供:米国国立医学図書館(NLM)

Genetic Testing and Epilepsy Management: A Camel's Journey Through the Desert of Neurological Disorders

Epilepsy, a neurological disorder characterized by recurrent seizures, can significantly impact quality of life. This study explores the role of genetic testing in informing epilepsy treatment management, examining how genetic diagnoses influence clinical decision-making and patient outcomes. The researchers retrospectively analyzed data from 418 patients with epilepsy who underwent multigene panel testing, assessing the impact of genetic diagnoses on treatment changes, medication adjustments, and overall outcomes.

Genetic Testing: A Guiding Star in the Desert of Epilepsy Management

The study reveals that a genetic diagnosis is often associated with significant changes in clinical management for patients with epilepsy, including medication adjustments, referrals to specialists, and increased vigilance for potential complications. These findings underscore the potential of genetic testing to personalize epilepsy treatment and improve patient outcomes.

Harnessing the Power of Genetics: A Camel's Perspective on Epilepsy Management

This research provides a compelling case for integrating genetic testing into the management of epilepsy, emphasizing the importance of personalized medicine in addressing this complex neurological disorder. By understanding the underlying genetic factors contributing to epilepsy, clinicians can develop more effective treatment plans, optimize medication choices, and ultimately improve patient outcomes.

Dr. Camel's Conclusion

This research offers a valuable perspective on the role of genetic testing in epilepsy management, highlighting its potential to personalize treatment and enhance patient outcomes. The study's findings emphasize the importance of incorporating genetic information into clinical decision-making, paving the way for more effective and tailored approaches to epilepsy care.

Date :
  1. Date Completed 2022-12-14
  2. Date Revised 2023-04-12
Further Info :

Pubmed ID

36315135

DOI: Digital Object Identifier

PMC9623482

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.